A proteomic study of the regulatory role for STAT-1 in cytokine-induced beta-cell death

Dieter Rondas1, Valborg Gudmundsdottir2, Wannes D'Hertog1

  • 1Division of Clinical and Experimental Endocrinology, KU Leuven, Leuven, Belgium.

Abstract

Insights

Signal transducer and activator of transcription 1 (STAT-1) is key in type 1 diabetes (T1D) beta-cell destruction. Proteomic analysis reveals STAT-1 regulates proteins involved in synthesis and processing, with SUMO4 playing a central role.

Area of Science:

  • Immunology
  • Proteomics
  • Endocrinology

Background:

  • Signal transducer and activator of transcription 1 (STAT-1) is implicated in cytokine-induced beta-cell destruction.
  • The specific downstream molecular pathways regulated by STAT-1 remain incompletely understood.

Purpose of the Study:

  • To conduct a proteome analysis of cytokine-exposed C57Bl/6 and STAT-1 knockout mouse islets.
  • To identify and prioritize proteins potentially involved in type 1 diabetes (T1D) pathogenesis.

Main Methods:

  • Differential protein identification using 2D-DIGE and MALDI-TOF/TOF.
  • Ingenuity Pathway Analysis (IPA) and protein-protein interaction network construction.
  • Phenome-interactome ranking to assess T1D relevance.

Main Results:

  • Identification of numerous STAT-1-regulated proteins, notably those in protein synthesis and processing.
  • Network analysis revealed complex interactions among functional protein groups.
  • IPA confirmed STAT-1 deletion's protective effect against cytokine-induced beta-cell death, highlighting small ubiquitin-related modifier 4 (SUMO4) as central.

Conclusions:

  • STAT-1 plays a critical role in inflammation-induced pancreatic islet destruction.
  • This study elucidates the proteomic pathways underlying STAT-1's function in islet inflammation.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K